Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature. - Wikidata - awgldk - TriplyDB

Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.

Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.

http://www.wikidata.org/entity/Q38114366

about

An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.Breast metastasis of salivary duct carcinoma in a patient: a case report.Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.Is there a role of adjuvant treatment for salivary duct carcinoma?Salivary Duct Carcinoma of the Parotid: Outcomes with a Contemporary Multidisciplinary Treatment Approach.Somatic mutations in salivary duct carcinoma and potential therapeutic targets.HER2/HER3-positive metastatic salivary duct carcinoma in the pleural effusion: A case report.Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.Metastatic HER-2-positive salivary gland carcinoma treated with trastuzumab and a taxane: a series of six patients.Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis.

P2860

Q33619720-E1000602-D7DC-4382-A0FC-D21C5F381A91 Q35230643-2ACF4C3C-A279-4879-A7E3-10906A8B91CD Q36493317-892C25BB-4C77-4150-AC49-6CF9FB180197 Q36874710-90E264FC-B9E4-4C3C-8E12-7AB28237A98E Q38364289-9EA4E398-5C13-45D8-AB58-214A75D131AF Q38776386-B3A34FC9-5BDE-4DCF-9FF8-F012CEF65F6E Q47133482-606F0001-17C8-4576-85E8-453FCE63A875 Q47330018-3ED8B0D1-428E-4C9A-8331-C5061D9436D9 Q50675747-4025D8E9-BEEF-4FE2-86F1-824525563C1B Q51709905-8223A1D6-FCE0-4A9B-B953-5623ED0ABBF0 Q54997136-171761EC-FE07-48D1-A925-62667E47B635

P2860

Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.

http://www.wikidata.org/entity/Q38114366

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Salivary duct carcinoma respon ...... and review of the literature.

@en

type

label

Salivary duct carcinoma respon ...... and review of the literature.

@en

prefLabel

Salivary duct carcinoma respon ...... and review of the literature.

@en

P1433

Q38114366-48779337-2A4D-477F-98A5-7DFB7C39DD04

P1476

Q38114366-D0D11F54-9F2A-4383-82B5-03726608BA4A

P2093

Q38114366-2E34F4BB-B097-43FA-A9D2-29200ACD1B03

Q38114366-5E5EA084-5AA6-48FB-9D9B-F0F5F535128F

Q38114366-672C3FE0-A4DF-40BF-A6EF-3954A7646484

Q38114366-82253D9F-4D05-4EB8-A9FC-9B0B14068CC0

Q38114366-85640B4F-5E7E-4133-B6DB-D9B74AE6C902

P2860

Q38114366-0CAD0CDC-C1AD-4259-9E32-A831E055D633

Q38114366-0FFCF566-F2DC-417F-A0F8-9F646C044A9E

Q38114366-3B0B999B-079B-4CE9-A1C2-C77A71455E18

Q38114366-3B69C3F4-1A71-4F3D-BC06-86532E45EE2C

Q38114366-3C028D9E-1A74-47A5-BDE1-B24531AB1383

Q38114366-400D9638-0846-4640-9209-AA2E02E26BA5

Q38114366-57CD5D57-AE36-4464-B479-1C090AB58555

Q38114366-6908D409-BC66-4CA1-8092-4456370A5270

Q38114366-8263B1EB-BAF2-4C2E-9E52-E4F6FF1466C0

Q38114366-892325FC-09B0-4E6E-8782-B4F90BA4F881

P304

Q38114366-2B418DCF-030B-47E2-97F2-56F56D4F779E

P31

Q38114366-27802E21-F861-4B02-B19D-7F102345D788

P356

Q38114366-63B04617-69AA-4822-AEA8-E9ADA57F016B

P433

Q38114366-12C2ED9B-90C9-4E85-913A-5519659BA8B7

P478

Q38114366-4D546702-6D55-4E5B-9B04-95A589D5985C

P50

Q38114366-5607DD1B-EB75-4EA5-942F-087371A08FCC

P577

Q38114366-15E110D5-9E77-4DA8-8CD1-9DE144B4E6B8

P5875

Q38114366-26E2C414-7EBE-4081-BF0B-9DF64C303C39

P698

Q38114366-8F1CE6C7-1B8F-4DE1-B54E-44BC0B47704C

P356

P1433

P1476

Salivary duct carcinoma respon ...... t and review of the literature

@en

P2093

Daniel Lydiatt

http://www.w3.org/2001/XMLSchema#string

Devi Mukkai Krishnamurty

http://www.w3.org/2001/XMLSchema#string

Jairam Krishnamurthy

http://www.w3.org/2001/XMLSchema#string

John J Baker

http://www.w3.org/2001/XMLSchema#string

Weining Zhen

http://www.w3.org/2001/XMLSchema#string

P2860

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis.

Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour.

A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma

Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein.

Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.

Salivary duct carcinoma: clinical characteristics and treatment strategies.

Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review.

Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.

P304

E372-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HED.23307

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Apar Kishor Ganti

P577

2013-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237823016

http://www.w3.org/2001/XMLSchema#string

P698

23765450

http://www.w3.org/2001/XMLSchema#string